Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Vaughan

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Kidney International|April 13, 2007
Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiencyN J Brown, J Bradford, Z Wang, et al.
Kidney International|September 6, 2000
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivoN J Brown, S Nakamura, L Ma, et al.
Circulation Research|January 1, 1996
Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cellsE Lee, D E Vaughan, S H Parikh, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic miceM Eren, C A Painter, L A Gleaves, et al.
The American Journal of Cardiology|December 1, 1988
Frequency of hypercholesterolemia after cardiac transplantationJ S Stamler, D E Vaughan, M A Rudd, et al.
The American Journal of Cardiology|September 15, 1989
Lovastatin therapy for hypercholesterolemia in cardiac transplant recipientsP C Kuo, J M Kirshenbaum, J Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 productionN J Brown, K S Kim, Y Q Chen, et al.
Circulation|May 1, 1992
Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitorP M Ridker, D E Vaughan, M J Stampfer, et al.
Journal of the American College of Cardiology|October 8, 1997
Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study InvestigatorsR M Lang, U Elkayam, L G Yellen, et al.
Lancet (London, England)|August 6, 1988
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolismS Z Goldhaber, C M Kessler, J Heit, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Kidney International|April 13, 2007
Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiencyN J Brown, J Bradford, Z Wang, et al.
Kidney International|September 6, 2000
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivoN J Brown, S Nakamura, L Ma, et al.
Circulation Research|January 1, 1996
Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cellsE Lee, D E Vaughan, S H Parikh, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic miceM Eren, C A Painter, L A Gleaves, et al.
The American Journal of Cardiology|December 1, 1988
Frequency of hypercholesterolemia after cardiac transplantationJ S Stamler, D E Vaughan, M A Rudd, et al.
The American Journal of Cardiology|September 15, 1989
Lovastatin therapy for hypercholesterolemia in cardiac transplant recipientsP C Kuo, J M Kirshenbaum, J Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 productionN J Brown, K S Kim, Y Q Chen, et al.
Circulation|May 1, 1992
Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitorP M Ridker, D E Vaughan, M J Stampfer, et al.
Journal of the American College of Cardiology|October 8, 1997
Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study InvestigatorsR M Lang, U Elkayam, L G Yellen, et al.
Lancet (London, England)|August 6, 1988
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolismS Z Goldhaber, C M Kessler, J Heit, et al.
Pageof 9